Ad is loading...
MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.
RGLS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Regulus Therapeutics (RGLS) Earnings Date & Reports

A.I. Advisor
published Earnings

RGLS is expected to report earnings to fall 17.95% to -17 cents per share on March 20

Regulus Therapeutics RGLS Stock Earnings Reports
Q4'24
Est.
$-0.17
Q3'24
Missed
by $0.04
Q2'24
Missed
by $0.05
Q1'24
Missed
by $0.07
Q4'23
Est.
$-0.40
The last earnings report on November 07 showed earnings per share of -20 cents, missing the estimate of -17 cents. With 261.91K shares outstanding, the current market capitalization sits at 93.67M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
RGLS
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View Trends For RGLS
(Try 14 days for Free)
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
4224 Campus Point Court
Phone
+1 858 202-6300
Employees
30
Web
https://www.regulusrx.com